CagriSema (cagrilintide + semaglutide) CagriSema is the most directly comparable combination because it also pairs cagrilintide with a GLP-1 agonist
Phase 2 data showed improvements in fasting glucose, HbA1c, insulin sensitivity, triglycerides, waist circumference, and liver fat content measured by MRI
Limited data
Initially developed to manage type 2 diabetes, these medications help by curbing appetite, slowing digestion, and keeping blood sugar levels in check
Benefits BPC-157 is a precision-formulated peptide designed to support healthy tissue repair, gastrointestinal integrity, circulatory function, and balanced inflammatory response.* This innovative formula features BPC-157 (500 mcg), combined with Sodium Bicarbonate and L-Lysine HCl to provide a comprehensive foundation for stability and targeted nutritional support